Related Experiment Video
Updated: Jul 3, 2026
07:49
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Reticuloendothelium malignancy: current role of imaging
Sunit Sebastian1, Brian C Lucey
1Department of Radiology, Emory University School of Medicine, 1364 Clifton Road, Atlanta, GA 30324, USA.
Cancer Treatment and Research
|July 16, 2008
Summary
Imaging techniques like CT, MRI, and PET/CT are crucial for diagnosing and managing lymphoma. PET/CT excels at detecting residual disease after treatment, improving patient outcomes.
Area of Science:
- Medical imaging
- Oncology
- Radiology
Background:
- Imaging is vital for lymphoma diagnosis, staging, and patient management.
- Computed tomography (CT) and magnetic resonance imaging (MRI) are primary modalities.
- Positron emission tomography/computed tomography (PET/CT) is increasingly important.
Purpose of the Study:
- To review the role of different imaging modalities in lymphoma patient care.
- To compare the effectiveness of CT, MRI, and PET/CT in lymphoma diagnosis and follow-up.
Main Methods:
- Review of current literature on imaging in lymphoma.
- Discussion of the applications of CT, MRI, and PET/CT.
Main Results:
- CT is widely used for lymphoma diagnosis and staging.
- MRI offers comparable utility to CT in initial patient work-up.
- PET/CT demonstrates superior sensitivity for detecting residual disease post-treatment.
Conclusions:
- CT and MRI are essential for initial lymphoma assessment.
- PET/CT is highly effective for evaluating treatment response and detecting residual disease.
- Advanced imaging techniques significantly impact lymphoma patient management and outcomes.
